Physician

Nicole Jasmyn Bright, D.O

According to 2025 Medicare claims, Nicole Bright, D.O (NPI: 1578722856) practices dermatology in the Dover, DE market, with the plurality of this provider's patient population coming from Kent, DE. This provider's primary affiliated billing organization is BURKE DERMATOLOGY, PA (NPI: 1871646919; TIN: 205734928) and primary practice location at 19901-5148.

Bright's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,829 traditional Medicare patients, billed 7,825 HCPCS/CPT codes, and received $575,636 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 2,890 prescription claims across 965 beneficiaries totaling $2,724,250 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 219 records totaling $5,017. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $324,751 to $575,636. Similarly, Part D prescription costs have moved sharply higher in recent years, from $71,444 to $2,724,250. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$311K$623K2015 Medicare payment: $324,751 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $279,741 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $326,871 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $620,796 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $600,716 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $472,764 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $622,759 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $622,153 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $501,589 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $575,636 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154623,699$324,751
20164993,668$279,741
20171,3385,298$326,871
20181,4267,025$620,796
20191,4317,023$600,716
20201,3375,491$472,764
20211,5517,510$622,759
20221,6037,556$622,153
20231,5136,978$501,589
20241,8297,825$575,636

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.7M2015 Drug cost: $71,444 (USD; Tot_Drug_Cst)2016 Drug cost: $53,768 (USD; Tot_Drug_Cst)2017 Drug cost: $162,073 (USD; Tot_Drug_Cst)2018 Drug cost: $416,278 (USD; Tot_Drug_Cst)2019 Drug cost: $542,483 (USD; Tot_Drug_Cst)2020 Drug cost: $591,774 (USD; Tot_Drug_Cst)2021 Drug cost: $1,161,808 (USD; Tot_Drug_Cst)2022 Drug cost: $1,738,384 (USD; Tot_Drug_Cst)2023 Drug cost: $1,764,810 (USD; Tot_Drug_Cst)2024 Drug cost: $2,724,250 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015216645$71,444
2016212591$53,768
2017410845$162,073
20185451,392$416,278
20196501,689$542,483
20206441,813$591,774
20218032,208$1,161,808
20227982,396$1,738,384
20238242,538$1,764,810
20249652,890$2,724,250

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth507574$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,1041,568$68
17000Destruction of precancer skin growth, 1 growth611780$46
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more440600$43
17003Destruction of precancer skin growth, 2-14 growths4522,530$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa211,372$452,849
Dupixent PenDupilumab953,052$412,039
TremfyaGuselkumab241,316$299,604
OtezlaApremilast451,406$222,258
RinvoqUpadacitinib25750$179,598

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.219$5,017LEO Pharma Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nicole Jasmyn Bright, D.O?

Tedicare shows public-source Medicare data for Nicole Jasmyn Bright, D.O (NPI 1578722856), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicole Jasmyn Bright, D.O have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nicole Jasmyn Bright, D.O?

Nicole Jasmyn Bright, D.O is linked to BURKE DERMATOLOGY, PA (billing NPI 1871646919) in the available physician profile data.

Does Nicole Jasmyn Bright, D.O have Open Payments data?

Nicole Jasmyn Bright, D.O has 219 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.